183 filings
10-Q
2024 Q1
IRON
Disc Medicine Inc
Quarterly report
9 May 24
8:15am
8-K
IRON
Disc Medicine Inc
9 May 24
Disc Medicine Reports First Quarter 2024 Financial Results and Provides Business Update
8:07am
ARS
2023 FY
IRON
Disc Medicine Inc
1 May 24
Annual report to shareholders
5:00pm
DEF 14A
IRON
Disc Medicine Inc
Definitive proxy
1 May 24
5:00pm
DEFA14A
IRON
Disc Medicine Inc
1 May 24
Additional proxy soliciting materials
5:00pm
8-K
2iwptt
2 Apr 24
Regulation FD Disclosure
5:25pm
S-8
a0le58n
21 Mar 24
Registration of securities for employees
8:54am
8-K
h4dwowive01zkqbjb
21 Mar 24
Disc Medicine Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
8:00am
8-K
gwcnyj3
26 Feb 24
Disc Medicine Expands Leadership Team with Appointment of Industry Veteran Pamela Stephenson, MPH as Chief Commercial Officer
8:43am
8-K
hpvxc4du k21
7 Feb 24
Departure of Directors or Certain Officers
8:10am
8-K
wwh4f 0lpneli5fi7o
11 Dec 23
Regulation FD Disclosure
8:35pm
8-K
hipy291a9l
11 Dec 23
Disc Presents Initial Positive Data from Ongoing Phase 1b/2 Trial of DISC-0974 in Patients with Myelofibrosis (MF) and Anemia at the 65th American Society of
12:11pm
EFFECT
cv6nqyk3kvzrvlldvv6u
7 Dec 23
Notice of effectiveness
12:15am
8-K
6lim05e89bzu86bvqgjj
5 Dec 23
Entry into a Material Definitive Agreement
4:56pm
POS AM
mkt k0cw068
5 Dec 23
Prospectus update (post-effective amendment)
4:53pm
424B5
u4nsi9 yv
5 Dec 23
Prospectus supplement for primary offering
4:51pm
EFFECT
0d212qfefop623n2hv
30 Nov 23
Notice of effectiveness
12:15am
CORRESP
k3sdxwnrt5wwckiggn
27 Nov 23
Correspondence with SEC
12:00am
UPLOAD
z603k
27 Nov 23
Letter from SEC
12:00am